229 related articles for article (PubMed ID: 35086255)
1. Localized surgical debridement for the management of orbital mucormycosis.
Murthy R; Gote YS; Bagchi A
Indian J Ophthalmol; 2022 Feb; 70(2):649-652. PubMed ID: 35086255
[TBL] [Abstract][Full Text] [Related]
2. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable.
Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R
Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.
Sen M; Honavar SG; Bansal R; Sengupta S; Rao R; Kim U; Sharma M; Sachdev M; Grover AK; Surve A; Budharapu A; Ramadhin AK; Tripathi AK; Gupta A; Bhargava A; Sahu A; Khairnar A; Kochar A; Madhavani A; Shrivastava AK; Desai AK; Paul A; Ayyar A; Bhatnagar A; Singhal A; Nikose AS; Bhargava A; Tenagi AL; Kamble A; Nariani A; Patel B; Kashyap B; Dhawan B; Vohra B; Mandke C; Thrishulamurthy C; Sambare C; Sarkar D; Mankad DS; Maheshwari D; Lalwani D; Kanani D; Patel D; Manjandavida FP; Godhani F; Agarwal GA; Ravulaparthi G; Shilpa GV; Deshpande G; Thakkar H; Shah H; Ojha HR; Jani H; Gontia J; Mishrikotkar JP; Likhari K; Prajapati K; Porwal K; Koka K; Dharawat KS; Ramamurthy LB; Bhattacharyya M; Saini M; Christy MC; Das M; Hada M; Panchal M; Pandharpurkar M; Ali MO; Porwal M; Gangashetappa N; Mehrotra N; Bijlani N; Gajendragadkar N; Nagarkar NM; Modi P; Rewri P; Sao P; Patil PS; Giri P; Kapadia P; Yadav P; Bhagat P; Parekh R; Dyaberi R; Chauhan RS; Kaur R; Duvesh RK; Murthy R; Dandu RV; Kathiara R; Beri R; Pandit R; Rani RH; Gupta R; Pherwani R; Sapkal R; Mehta R; Tadepalli S; Fatima S; Karmarkar S; Patil SS; Shah S; Shah S; Shah S; Dubey S; Gandhi S; Kanakpur S; Mohan S; Bhomaj S; Kerkar S; Jariwala S; Sahu S; Tara S; Maru SK; Jhavar S; Sharma S; Gupta S; Kumari S; Das S; Menon S; Burkule S; Nisar SP; Kaliaperumal S; Rao S; Pakrasi S; Rathod S; Biradar SG; Kumar S; Dutt S; Bansal S; Ravani SA; Lohiya S; Ali Rizvi SW; Gokhale T; Lahane TP; Vukkadala T; Grover T; Bhesaniya T; Chawla U; Singh U; Une VL; Nandedkar V; Subramaniam V; Eswaran V; Chaudhry VN; Rangarajan V; Dehane V; Sahasrabudhe VM; Sowjanya Y; Tupkary Y; Phadke Y;
Indian J Ophthalmol; 2021 Jul; 69(7):1670-1692. PubMed ID: 34156034
[TBL] [Abstract][Full Text] [Related]
4. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report.
Veisi A; Bagheri A; Eshaghi M; Rikhtehgar MH; Rezaei Kanavi M; Farjad R
Eur J Ophthalmol; 2022 Jul; 32(4):NP11-NP16. PubMed ID: 33843287
[TBL] [Abstract][Full Text] [Related]
5. Rise of the phoenix: Mucormycosis in COVID-19 times.
Ravani SA; Agrawal GA; Leuva PA; Modi PH; Amin KD
Indian J Ophthalmol; 2021 Jun; 69(6):1563-1568. PubMed ID: 34011742
[TBL] [Abstract][Full Text] [Related]
6. Retrobulbar injection of amphotericin B using intravenous cannula for post-COVID-19 rhino-orbital mucormycosis.
Murthy R; Bagchi A; Gote Y; Desai S
Indian J Ophthalmol; 2022 Jan; 70(1):302-305. PubMed ID: 34937263
[TBL] [Abstract][Full Text] [Related]
7. Non-sinonasal isolated facio-orbital mucormycosis - A case report.
Swain SK; Sahu MC; Banerjee A
J Mycol Med; 2018 Sep; 28(3):538-541. PubMed ID: 29773436
[TBL] [Abstract][Full Text] [Related]
8. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
[TBL] [Abstract][Full Text] [Related]
9. Scoring system evaluation for orbital exenteration in patients with rhino-orbito-cerebral mucormycosis.
Ulas B; Kursun E; Turunc T; Demıroglu YZ; Pelıt A
J Fr Ophtalmol; 2022 Jan; 45(1):47-52. PubMed ID: 34823889
[TBL] [Abstract][Full Text] [Related]
10. Outcome of transcutaneous retrobulbar injection of liposomal amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: Our experience.
Ramamurthy LB; Bhandari R; Kanakpur S; Thejaswini P
Indian J Ophthalmol; 2022 Mar; 70(3):1019-1024. PubMed ID: 35225564
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations.
Bayram N; Ozsaygılı C; Sav H; Tekin Y; Gundogan M; Pangal E; Cicek A; Özcan İ
Jpn J Ophthalmol; 2021 Jul; 65(4):515-525. PubMed ID: 34057620
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
[TBL] [Abstract][Full Text] [Related]
13. Non-Exenteration Management of Sino-Orbital Fungal Disease.
Athavale DD; Jones R; O'Donnell BA; Forer M; Biggs N
Ophthalmic Plast Reconstr Surg; 2017; 33(6):426-429. PubMed ID: 27768645
[TBL] [Abstract][Full Text] [Related]
14. Retrobulbar Injection of Amphotericin B for Orbital Mucormycosis.
Hirabayashi KE; Kalin-Hajdu E; Brodie FL; Kersten RC; Russell MS; Vagefi MR
Ophthalmic Plast Reconstr Surg; 2017; 33(4):e94-e97. PubMed ID: 27768642
[TBL] [Abstract][Full Text] [Related]
15. Retrobulbar Injection of Amphotericin B in Patients With COVID-19 Associated Orbital Mucormycosis: A Systematic Review.
Sharifi A; Akbari Z; Shafie'ei M; Nasiri N; Sharifi M; Shafiei M; Zand A
Ophthalmic Plast Reconstr Surg; 2022 Sep-Oct 01; 38(5):425-432. PubMed ID: 35943425
[TBL] [Abstract][Full Text] [Related]
16. Post-COVID-19 rhino-orbito-cerebral mucormycosis: a new addition to challenges in pandemic control.
Mitra S; Janweja M; Sengupta A
Eur Arch Otorhinolaryngol; 2022 May; 279(5):2417-2422. PubMed ID: 34309754
[TBL] [Abstract][Full Text] [Related]
17. Orbital exenteration: A dilemma in mucormycosis presented with orbital apex syndrome.
Songu M; Unlu HH; Gunhan K; Ilker SS; Nese N
Am J Rhinol; 2008; 22(1):98-103. PubMed ID: 18284868
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of rhino-orbital mucormycosis without exenteration: the use of multiple treatment modalities.
Pelton RW; Peterson EA; Patel BC; Davis K
Ophthalmic Plast Reconstr Surg; 2001 Jan; 17(1):62-6. PubMed ID: 11206749
[TBL] [Abstract][Full Text] [Related]
19. Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center.
Singh SP; Rana J; Singh VK; Singh R; Sachan R; Singh S; Jain S
Rom J Ophthalmol; 2021; 65(4):339-353. PubMed ID: 35087975
[No Abstract] [Full Text] [Related]
20. Intraconal amphotericin B for the treatment of rhino-orbital mucormycosis.
Luna JD; Ponssa XS; Rodríguez SD; Luna NC; Juárez CP
Ophthalmic Surg Lasers; 1996 Aug; 27(8):706-8. PubMed ID: 8858637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]